Outcomes of intermediate-risk to high-risk stage I endometrial cancer: 10-year clinical experiences of using in-house multi-channel applicators in a single center.
CONCLUSIONS: For patients with IR to HR stage I EC, adjuvant VBT alone or in combination with EBRT using IH-MCA led to excellent survival and recurrence rates. Age and grade were the prognostic factors correlated with OS.
PMID: 31365429 [PubMed - as supplied by publisher]
Source: Chinese Medical Journal - Category: General Medicine Authors: Hou XR, Yu L, Hu K, Zhang FQ Tags: Chin Med J (Engl) Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | China Health | Endometrial Cancer | External Beam Therapy | General Medicine | Hysterectomy